SORBS2 transcription is activated by telomere position effect-over long distance upon telomere shortening in muscle cells from patients with facioscapulohumeral dystrophy

Genome Research

Volumn 25, Issue 12, 2015, Pages 1781-1790

  Robin, Jérôme D ^a   Ludlow, Andrew T ^a   Batten, Kimberly ^a   Gaillard, Marie Cécile ^b   Stadler, Guido ^a   Magdinier, Frédérique ^b   Wright, Woodring E ^a   Shay, Jerry W ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b AIX MARSEILLE UNIVERSITY   (France)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; DNA; MUSCLE PROTEIN; SH3 DOMAIN CONTAINING PROTEIN 2 PROTEIN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; SORBS2 PROTEIN, HUMAN;

ARTICLE; CHROMOSOME 4; CHROMOSOME STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCUS; HUMAN; HUMAN CELL; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; POSITION EFFECT; PRIORITY JOURNAL; SKELETAL MUSCLE; TELOMERE; TELOMERE SHORTENING; TRANSCRIPTION INITIATION; UPREGULATION; BIOPSY; CHROMOSOME DELETION; EPISTASIS; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; METABOLISM; PATHOLOGY;

BIOPSY; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 4; DNA METHYLATION; EPISTASIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC LOCI; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MUSCLE CELLS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS; MYOD PROTEIN; TELOMERE; TELOMERE SHORTENING; TRANSCRIPTIONAL ACTIVATION;

EID: 84951105717     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.190660.115     Document Type: Article

References (82)

1. Anderson MZ, Gerstein AC, Wigen L, Baller JA, Berman J. 2014. Silencing is noisy: Population and cell level noise in telomere-adjacent genes is dependent on telomere position and sir2. PLoS Genet 10: e1004436.
2. Arnoult N, Schluth-Bolard C, Letessier A, Drascovic I, Bouarich-Bourimi R, Campisi J, Kim SH, Boussouar A, Ottaviani A, Magdinier F, et al. 2010. Replication timing of human telomeres is chromosome arm-specific, influenced by subtelomeric structures and connected to nuclear localization. PLoS Genet 6: e1000920.
3. Balog J, Thijssen PE, de Greef JC, Shah B, van Engelen BG, Yokomori K, Tapscott SJ, Tawil R, van der Maarel SM. 2012. Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD. Epigenetics 7: 579-584.
4. Baur JA, Zou Y, Shay JW, Wright WE. 2001. Telomere position effect in human cells. Science 292: 2075-2077.
5. Blackburn EH. 2001. Switching and signaling at the telomere. Cell 106: 661-673.
6. Blewitt ME, Gendrel AV, Pang Z, Sparrow DB, Whitelaw N, Craig JM, Apedaile A, Hilton DJ, Dunwoodie SL, Brockdorff N, et al. 2008. SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation. Nat Genet 40: 663-669.
7. Block GJ, Narayanan D, Amell AM, Petek LM, Davidson KC, Bird TD, Tawil R, Moon RT, Miller DG. 2013. Wnt/β-catenin signaling suppresses DUX4 expression and prevents apoptosis of FSHD muscle cells. Hum Mol Genet 22: 4661-4672.
8. Bodega B, Ramirez GD, Grasser F, Cheli S, Brunelli S, Mora M, Meneveri R, Marozzi A, Mueller S, Battaglioli E, et al. 2009. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation. BMC Biol 7: 41.
9. Bosnakovski D, Xu Z, Gang EJ, Galindo CL, Liu M, Simsek T, Garner HR, Agha-Mohammadi S, Tassin A, Coppée F, et al. 2008. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J 27: 2766-2779.
10. Boussouar A, Barette C, Nadon R, Saint-Léger A, Broucqsault N, Ottaviani A, Firozhoussen A, Lu Y, Lafanechère L, Gilson E, et al. 2013. Acacetin and chrysin, two polyphenolic compounds, alleviate telomeric position effect in human cells. Mol Ther Nucleic Acids 2: e116.
11. Broucqsault N, Morere J, Gaillard MC, Dumonceaux J, Torrents J, Salort-Campana E, Maues De Paula A, Bartoli M, Fernandez C, Chesnais AL, et al. 2013. Dysregulation of 4q35-and muscle-specific genes in fetuses with a short D4Z4 array linked to facio-scapulo-humeral dystrophy. Hum Mol Genet 22: 4206-4214.
12. Buxton JL, Suderman M, Pappas JJ, Borghol N, McArdle W, Blakemore AI, Hertzman C, Power C, Szyf M, Pembrey M. 2014. Human leukocyte telomere length is associated with DNA methylation levels in multiple subtelomeric and imprinted loci. Sci Rep 4: 4954.
13. Cabianca DS, Casa V, Bodega B, Xynos A, Ginelli E, Tanaka Y, Gabellini D. 2012. A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell 149: 819-831.
14. Campisi J. 1997. The biology of replicative senescence. Eur J Cancer 33: 703-709.
15. Caruso N, Herberth B, Bartoli M, Puppo F, Dumonceaux J, Zimmermann A, Denadai S, Lebossé M, Roche S, Geng L, et al. 2013. Deregulation of the protocadherin gene FAT1 alters muscle shapes: implications for the pathogenesis of facioscapulohumeral dystrophy. PLoS Genet 9: e1003550.
16. Celegato B, Capitanio D, Pescatori M, Romualdi C, Pacchioni B, Cagnin S, Viganò A, Colantoni L, Begum S, Ricci E, et al. 2006. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 6: 5303-5321.
17. Cheli S, Francois S, Bodega B, Ferrari F, Tenedini E, Roncaglia E, Ferrari S, Ginelli E, Meneveri R. 2011. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. PLoS One 6: e20966.
18. d'Adda di Fagagna F, Teo SH, Jackson SP. 2004. Functional links between telomeres and proteins of the DNA-damage response. Genes Dev 18: 1781-1799.
19. Daniali L, Benetos A, Susser E, Kark JD, Labat C, Kimura M, Desai K, Granick M, Aviv A. 2013. Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun 4: 1597.
20. Decary S, Hamida CB, Mouly V, Barbet JP, Hentati F, Butler-Browne GS. 2000. Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children. Neuromuscul Disord 10: 113-120.
21. Deenen JC, Arnts H, van der Maarel SM, Padberg GW, Verschuuren JJ, Bakker E, Weinreich SS, Verbeek AL, van Engelen BG. 2014. Population-based incidence and prevalence of facioscapulohumeral dystrophy. Neurology 83: 1056-1059.
22. Dixit M, Ansseau E, Tassin A, Winokur S, Shi R, Qian H, Sauvage S, Mattéotti C, van Acker AM, Leo O, et al. 2007. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc Natl Acad Sci 104: 18157-18162.
23. Ferreboeuf M, Mariot V, Bessières B, Vasiljevic A, Attié-Bitach T, Collardeau S, Morere J, Roche S, Magdinier F, Robin-Ducellier J, et al. 2014. DUX4 and DUX4 downstream target genes are expressed in fetal FSHD muscles. Hum Mol Genet 23: 171-181.
24. Ferreira HC, Towbin BD, Jegou T, Gasser SM. 2013. The shelterin protein POT-1 anchors Cænorhabditis elegans telomeres through SUN-1 at the nuclear periphery. J Cell Biol 203: 727-735.
25. Fourel G, Revardel E, Koering CE, Gilson E. 1999. Cohabitation of insulators and silencing elements in yeast subtelomeric regions. EMBO J 18: 2522-2537.
26. Gabriëls J, Beckers MC, Ding H, De Vriese A, Plaisance S, van der Maarel SM, Padberg GW, Frants RR, Hewitt JE, Collen D, et al. 1999. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. Gene 236: 25-32.
27. Gaillard MC, Roche S, Dion C, Tasmadjian A, Bouget G, Salort-Campana E, Vovan C, Chaix C, Broucqsault N, Morere J, et al. 2014. Differential DNA methylation of the D4Z4 repeat in patients with FSHD and asymptomatic carriers. Neurology 83: 733-742.
28. Geng LN, Yao Z, Snider L, Fong AP, Cech JN, Young JM, van der Maarel SM, Ruzzo WL, Gentleman RC, Tawil R, et al. 2012. DUX4 activates germline genes, retroelements, and immune mediators: implications for facioscapulohumeral dystrophy. Dev Cell 22: 38-51.
29. Gilson E, Geli V. 2007. How telomeres are replicated. Nat Rev Mol Cell Biol 8: 825-838.
30. Haglund K, Ivankovic-Dikic I, Shimokawa N, Kruh GD, Dikic I. 2004. Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for actin reorganization in growing neurites. J Cell Sci 117: 2557-2568.
31. Heinz S, Benner C, Spann N, Bertolino E, Lin YC, Laslo P, Cheng JX, Murre C, Singh H, Glass CK. 2010. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38: 576-589.
32. Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M. 2003. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 12: 2909-2921.
33. Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP Jr, et al. 2012. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet 21: 4419-4430.
34. Jones TI, Yan C, Sapp PC, McKenna-Yasek D, Kang PB, Quinn C, Salameh JS, King OD, Jones PL. 2014. Identifying diagnostic DNA methylation profiles for facioscapulohumeral muscular dystrophy in blood and saliva using bisulfite sequencing. Clin Epigenetics 6: 23.
35. Koering CE, Pollice A, ZibellaMP, Bauwens S, Puisieux A, Brunori M, Brun C, Martins L, Sabatier L, Pulitzer JF, et al. 2002. Human telomeric position effect is determined by chromosomal context and telomeric chromatin integrity. EMBO Rep 3: 1055-1061.
36. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, Jones SJ, MarraMA. 2009. Circos: an information æsthetic for comparative genomics. Genome Res 19: 1639-1645.
37. Lamberti A, Sanges C, Chambery A, Migliaccio N, Rosso F, Di Maro A, Papale F, Marra M, Parente A, Caraglia M, et al. 2011. Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics. Biochimie 93: 1738-1746.
38. Lemmers RJ, van der Vliet PJ, Klooster R, Sacconi S, Camaño P, Dauwerse JG, Snider L, Straasheijm KR, van Ommen GJ, Padberg GW, et al. 2010. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329: 1650-1653.
39. Lemmers RJ, Tawil R, Petek LM, Balog J, Block GJ, Santen GW, Amell AM, van der Vliet PJ, Almomani R, Straasheijm KR, et al. 2012. Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 44: 1370-1374.
40. Londoño-Vallejo JA, DerSarkissian H, Cazes L, Thomas G. 2001. Differences in telomere length between homologous chromosomes in humans. Nucleic Acids Res 29: 3164-3171.
41. Lou Z, Wei J, Riethman H, Baur JA, Voglauer R, Shay JW, Wright WE. 2009. Telomere length regulates ISG15 expression in human cells. Aging 1: 608-621.
42. Maillet L, Boscheron C, Gotta M, Marcand S, Gilson E, Gasser SM. 1996. Evidence for silencing compartments within the yeast nucleus: a role for telomere proximity and Sir protein concentration in silencer-mediated repression. Genes Dev 10: 1796-1811.
43. Mariot V, Roche S, Hourdé C, Portilho D, Sacconi S, Puppo F, Duguez S, Rameau P, Caruso N, Delezoide AL, et al. 2015. Correlation between low FAT1 expression and early affected muscle in FSHD. Ann Neurol 78: 387-400.
44. Masny PS, Chan OY, de Greef JC, Bengtsson U, Ehrlich M, Tawil R, Lock LF, Hewitt JE, Stocksdale J, Martin JH, et al. 2010. Analysis of allele-specific RNA transcription in FSHD by RNA-DNA FISH in single myonuclei. Eur J Hum Genet 18: 448-456.
45. Mason JM, Konev AY, Biessmann H. 2003. Telomeric position effect in Drosophila melanogaster reflects a telomere length control mechanism. Genetica 117: 319-325.
46. Millay DP, O'Rourke JR, Sutherland LB, Bezprozvannaya S, Shelton JM, Bassel-Duby R, Olson EN. 2013. Myomaker is a membrane activator of myoblast fusion and muscle formation. Nature 499: 301-305.
47. Millay DP, Sutherland LB, Bassel-Duby R, Olson EN. 2014. Myomaker is essential for muscle regeneration. Genes Dev 28: 1641-1646.
48. Mostacciuolo ML, Pastorello E, Vazza G, Miorin M, Angelini C, Tomelleri G, Galluzzi G, Trevisan CP. 2009. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Clin Genet 75: 550-555.
49. Murase K, Ito H, Kanoh H, Sudo K, Iwamoto I, Morishita R, Soubeyran P, Seishima M, Nagata K. 2012. Cell biological characterization of a multidomain adaptor protein, ArgBP2, in epithelial NMuMG cells, and identification of a novel short isoform. Med Mol Morphol 45: 22-28.
50. O'Sullivan RJ, Karlseder J. 2010. Telomeres: protecting chromosomes against genome instability. Nat Rev Mol Cell Biol 11: 171-181.
51. Ottaviani A, Gilson E, Magdinier F. 2008. Telomeric position effect: from the yeast paradigm to human pathologies? Biochimie 90: 93-107.
52. Ottaviani A, Rival-Gervier S, Boussouar A, Foerster AM, Rondier D, Sacconi S, Desnuelle C, Gilson E, Magdinier F. 2009. The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facioscapulo-humeral dystrophy. PLoS Genet 5: e1000394.
53. Padberg GW, Frants RR, Brouwer OF, Wijmenga C, Bakker E, Sandkuijl LA. 1995. Facioscapulohumeral muscular dystrophy in the Dutch population. Muscle Nerve Suppl 2: S81-S84.
54. Pastorello E, Cao M, Trevisan CP. 2012. Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy. Clin Neurol Neurosurg 114: 230-234.
55. Pedram M, Sprung CN, Gao Q, Lo AW, Reynolds GE, Murnane JP. 2006. Telomere position effect and silencing of transgenes near telomeres in the mouse. Mol Cell Biol 26: 1865-1878.
56. Pirozhkova I, Petrov A, Dmitriev P, Laoudj D, Lipinski M, Vassetzky Y. 2008. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy. PLoS One 3: e3389.
57. Pope BD, Tsumagari K, Battaglia D, Ryba T, Hiratani I, Ehrlich M, Gilbert DM. 2011. DNA replication timing is maintained genome-wide in primary human myoblasts independent of D4Z4 contraction in FSH muscular dystrophy. PLoS One 6: e27413.
58. Puppo F, Dionnet E, Gaillard MC, Gaildrat P, Castro C, Vovan C, Bertaux K, Bernard R, Attarian S, Goto K, et al. 2015. Identification of variants in the 4q35 gene FAT1 in patients with a facioscapulohumeral dystrophy-like phenotype. Hum Mutat 36: 443-453.
59. Rahimov F, King OD, Leung DG, Bibat GM, Emerson CP Jr, Kunkel LM, Wagner KR. 2012. Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers. Proc Natl Acad Sci 109: 16234-16239.
60. Robin JD, Ludlow AT, Batten K, Magdinier F, Stadler G, Wagner KR, ShayJW, Wright WE. 2014. Telomere position effect: regulation of gene expression with progressive telomere shortening over long distances. Genes Dev 28: 2464-2476.
61. Roignot J, Soubeyran P. 2009. ArgBP2 and the SoHo family of adapter proteins in oncogenic diseases. Cell Adh Migr 3: 167-170.
62. Roignot J, Bonacci T, Ghigo E, Iovanna JL, Soubeyran P. 2014. Oligomerization and phosphorylation dependent regulation of ArgBP2 adaptive capabilities and associated functions. PLoS One 9: e87130.
63. Sacconi S, Lemmers RJ, Balog J, van der Vliet PJ, Lahaut P, van Nieuwenhuizen MP, Straasheijm KR, Debipersad RD, Vos-Versteeg M, Salviati L, et al. 2013. The FSHD2 gene SMCHD1 is a modifier of disease severity in families affected by FSHD1. Am J Hum Genet 93: 744-751.
64. Sandell LL, Gottschling DE, Zakian VA. 1994. Transcription of a yeast telomere alleviates telomere position effect without affecting chromosome stability. Proc Natl Acad Sci 91: 12061-12065.
65. Sanger JM, Wang J, Gleason LM, Chowrashi P, Dube DK, Mittal B, Zhukareva V, Sanger JW. 2010. Arg/Abl-binding protein, a Z-body and Z-band protein, binds sarcomeric, costameric, and signaling molecules. Cytoskeleton 67: 808-823.
66. Scionti I, Greco F, Ricci G, Govi M, Arashiro P, Vercelli L, Berardinelli A, Angelini C, Antonini G, Cao M, et al. 2012. Large-scale population analysis challenges the current criteria for the molecular diagnosis of fascioscapulohumeral muscular dystrophy. Am J Hum Genet 90: 628-635.
67. Smith JS, Brachmann CB, Celic I, Kenna MA, Muhammad S, Starai VJ, Avalos JL, Escalante-Semerena JC, Grubmeyer C, Wolberger C, et al. 2000. A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc Natl Acad Sci 97: 6658-6663.
68. Snider L, Geng LN, Lemmers RJ, Kyba M, Ware CB, Nelson AM, Tawil R, Filippova GN, van der Maarel SM, Tapscott SJ, et al. 2010. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet 6: e1001181.
69. Stadler G, Rahimov F, King OD, Chen JC, Robin JD, Wagner KR, Shay JW, Emerson CP Jr, Wright WE. 2013. Telomere position effect regulates DUX4 in human facioscapulohumeral muscular dystrophy. Nat Struct Mol Biol 20: 671-678.
70. Tassin A, Laoudj-Chenivesse D, Vanderplanck C, Barro M, Charron S, Ansseau E, Chen YW, Mercier J, Coppée F, Belayew A. 2013. DUX4 expression in FSHD muscle cells: How could such a rare protein cause a myopathy? J Cell Mol Med 17: 76-89.
71. Tennen RI, Bua DJ, Wright WE, Chua KF. 2011. SIRT6 is required for maintenance of telomere position effect in human cells. Nat Commun 2: 433.
72. Tsumagari K, Qi L, Jackson K, Shao C, Lacey M, Sowden J, Tawil R, Vedanarayanan V, Ehrlich M. 2008. Epigenetics of a tandem DNA repeat: chromatin DNaseI sensitivity and opposite methylation changes in cancers. Nucleic Acids Res 36: 2196-2207.
73. Tsumagari K, Chang SC, Lacey M, Baribault C, Chittur SV, Sowden J, Tawil R, Crawford GE, Ehrlich M. 2011. Gene expression during normal and FSHD myogenesis. BMC Med Genomics 4: 67.
74. van Berkum NL, Lieberman-Aiden E, Williams L, Imakæv M, Gnirke A, Mirny LA, Dekker J, Lander ES. 2010. Hi-C: a method to study the three-dimensional architecture of genomes. J Vis Exp doi: 10.3791/ 1869.
75. van Geel M, Heather LJ, Lyle R, Hewitt JE, Frants RR, de Jong PJ. 1999. The FSHD region on human chromosome 4q35 contains potential coding regions among pseudogenes and a high density of repeat elements. Genomics 61: 55-65.
76. Vega-Palas MA, Venditti S, Di Mauro E. 1997. Telomeric transcriptional silencing in a natural context. Nat Genet 15: 232-233.
77. Wang B, Golemis EA, Kruh GD. 1997. ArgBP2, a multiple Src homology 3 domain-containing, Arg/Abl-interacting protein, is phosphorylated in v-Abl-transformed cells and localized in stress fibers and cardiocyte Zdisks. J Biol Chem 272: 17542-17550.
78. Weuts A, Voet T, Verbeeck J, Lambrechts N, Wirix E, Schoonjans L, Danloy S, Marynen P, Froyen G. 2012. Telomere length homeostasis and telomere position effect on a linear human artificial chromosome are dictated by the genetic background. Nucleic Acids Res 40: 11477-11489.
79. Winokur ST, Chen YW, Masny PS, Martin JH, Ehmsen JT, Tapscott SJ, van der Maarel SM, Hayashi Y, Flanigan KM. 2003. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 12: 2895-2907.
80. Wright WE, Shay JW. 1992. Telomere positional effects and the regulation of cellular senescence. Trends Genet 8: 193-197.
81. Ye J, Renault VM, Jamet K, Gilson E. 2014. Transcriptional outcome of telomere signalling. Nat Rev Genet 15: 491-503.
82. Zhou BO, Wang SS, Zhang Y, Fu XH, DangW, Lenzmeier BA, Zhou JQ. 2011. Histone H4 lysine 12 acetylation regulates telomeric heterochromatin plasticity in Saccharomyces cerevisiæ. PLoS Genet 7: e1001272.